Healios KK
TSE:4593

Watchlist Manager

Healios KK

TSE:4593

Watchlist

Dividends

Price: 517 JPY 2.78%

Market Cap: 52.5B JPY

Activate Unlimited Plan
to continue 4593 research

You've reached your weekly stock limit.

14-day money-back guarantee

Have any thoughts about
Healios KK?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 517 JPY

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

Alert

Healios KK

517

+14 (+2.78%)

52 Week Range	136 535
Price Target

We'll email you a reminder when the closing price reaches JPY.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Healios KK

What unique competitive advantages
does Healios KK hold over its rivals?

What risks and challenges
does Healios KK face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Healios KK.

What unique competitive advantages
does Healios KK hold over its rivals?

What risks and challenges
does Healios KK face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Healios KK.

Provide P/S
for Healios KK.

Provide P/E
for Healios KK.

Provide P/OCF
for Healios KK.

Provide P/FCFE
for Healios KK.

Provide P/B
for Healios KK.

Provide EV/S
for Healios KK.

Provide EV/GP
for Healios KK.

Provide EV/EBITDA
for Healios KK.

Provide EV/EBIT
for Healios KK.

Provide EV/OCF
for Healios KK.

Provide EV/FCFF
for Healios KK.

Provide EV/IC
for Healios KK.

Show me price targets
for Healios KK made by professional analysts.

What are the Revenue projections
for Healios KK?

How accurate were the past Revenue estimates
for Healios KK?

What are the Net Income projections
for Healios KK?

How accurate were the past Net Income estimates
for Healios KK?

What are the EPS projections
for Healios KK?

How accurate were the past EPS estimates
for Healios KK?

What are the EBIT projections
for Healios KK?

How accurate were the past EBIT estimates
for Healios KK?

Compare the revenue forecasts
for Healios KK with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Healios KK and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Healios KK against its competitors.

Analyze the profit margins
(gross, operating, and net) of Healios KK compared to its peers.

Compare the P/E ratios
of Healios KK against its peers.

Discuss the investment returns and shareholder value creation
comparing Healios KK with its peers.

Analyze the financial leverage
of Healios KK compared to its main competitors.

Show all profitability ratios
for Healios KK.

Provide ROE
for Healios KK.

Provide ROA
for Healios KK.

Provide ROIC
for Healios KK.

Provide ROCE
for Healios KK.

Provide Gross Margin
for Healios KK.

Provide Operating Margin
for Healios KK.

Provide Net Margin
for Healios KK.

Provide FCF Margin
for Healios KK.

Show all solvency ratios
for Healios KK.

Provide D/E Ratio
for Healios KK.

Provide D/A Ratio
for Healios KK.

Provide Interest Coverage Ratio
for Healios KK.

Provide Altman Z-Score Ratio
for Healios KK.

Provide Quick Ratio
for Healios KK.

Provide Current Ratio
for Healios KK.

Provide Cash Ratio
for Healios KK.

What is the historical Revenue growth
over the last 5 years for Healios KK?

What is the historical Net Income growth
over the last 5 years for Healios KK?

What is the current Free Cash Flow
of Healios KK?

Discuss the annual earnings per share (EPS)
trend over the past five years for Healios KK.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

Price Targets Summary
Healios KK

Wall Street analysts forecast Healios KK stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Healios KK is 391 JPY with a low forecast of 343.4 JPY and a high forecast of 441 JPY.

Lowest

Price Target

343.4 JPY

34% Downside

Average

Price Target

391 JPY

24% Downside

Highest

Price Target

441 JPY

15% Downside

Healios KK Competitors:
Price Targets

GILD

Gilead Sciences Inc

7% Upside

PAR

Paradigm Biopharmaceuticals Ltd

186% Upside

TNG

Transgene SA

74% Upside

OSE

OSE Immunotherapeutics SA

232% Upside

GILD

Gilead Sciences Inc

7% Upside

PAR

Paradigm Biopharmaceuticals Ltd

186% Upside

TNG

Transgene SA

74% Upside

OSE

OSE Immunotherapeutics SA

232% Upside

4587

PeptiDream Inc

120% Upside

BPMC

Blueprint Medicines Corp

0% Downside

688105

Nanjing Vazyme Biotech Co Ltd

11% Upside

Revenue
Forecast

Revenue Estimate
Healios KK

For the last 10 years the compound annual growth rate for Healios KK's revenue is 7%. The projected CAGR for the next 3 years is 105%.

Past Growth

105%

Estimated Growth

Estimates Accuracy

-10%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Healios KK

Operating Income forecast
is not available for
Healios KK

Net Income
Forecast

Net Income Estimate
Healios KK

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-28%

Average Miss

What are analyst estimates?

What is Healios KK's stock price target?

Price Target
391 JPY

According to Wall Street analysts, the average 1-year price target for Healios KK is 391 JPY with a low forecast of 343.4 JPY and a high forecast of 441 JPY.

What is Healios KK's Revenue forecast?

Projected CAGR
105%

For the last 10 years the compound annual growth rate for Healios KK's revenue is 7%. The projected CAGR for the next 3 years is 105%.

	Healios KK TSE:4593	517 JPY 2.78%
	Hycroft Mining Holding Corporation NASDAQ:HYMC	3.095 USD -8.97%
	Green Energy Enterprises Inc OTC:GYOG	0.0001 USD
N	Naspers Ltd JSE:NPN	531 250 Zac -2.29%
	Destination XL Group Inc NASDAQ:DXLG	1.12 USD -0.88%

	Franklin Covey Co NYSE:FC	22.64 USD -0.26%
	Mohawk Industries Inc NYSE:MHK	101.43 USD -3.19%
	Ardmore Shipping Corp NYSE:ASC	10.19 USD 2.93%
	ASGN Inc NYSE:ASGN	51.6 USD -2.49%
	Skyworks Solutions Inc NASDAQ:SWKS	71.25 USD -1.06%
	Weatherford International PLC NASDAQ:WFRD	53.025 USD 1.06%

	Johnson & Johnson NYSE:JNJ	157.1 USD 0.28%
	Bank of America Corp NYSE:BAC	44.09 USD -1.19%
	Mastercard Inc NYSE:MA	562.03 USD -4.62%
	Salesforce Inc NYSE:CRM	258.4 USD -3.19%
	Abbvie Inc NYSE:ABBV	191.08 USD -0.7%
	Home Depot Inc NYSE:HD	354.66 USD -2.34%

	Arista Networks Inc NYSE:ANET	92.35 USD -3.57%
	Deckers Outdoor Corp NYSE:DECK	101.48 USD -5.78%
	Visa Inc NYSE:V	352.85 USD -4.99%
	Texas Pacific Land Corp NYSE:TPL	1 119.58 USD 2.01%
	KLA Corp NASDAQ:KLAC	867.67 USD -0.84%
	Manhattan Associates Inc NASDAQ:MANH	189.31 USD -1.85%

	Salesforce Inc NYSE:CRM	258.4 USD -3.19%
	Accenture PLC NYSE:ACN	311.71 USD -2.02%
	ServiceNow Inc NYSE:NOW	988.66 USD -1.86%
	Spotify Technology SA NYSE:SPOT	710.85 USD 1.14%
	EOG Resources Inc NYSE:EOG	125.28 USD 3.89%
	Applied Materials Inc NASDAQ:AMAT	170.59 USD -2.52%

Healios KK
TSE:4593